Challenges and Best Practices for Initiating Venetoclax - Dr. Ryan Jacobs

While time-limited treatment for chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL / SLL) with venetoclax sounds appealing, its use remains low because it is more complicated to start than a BTK inhibitor. However, several best practices can be implemented by healthcare providers to support the initiation of venetoclax therapy.

Dr. Ryan Jacobs from Atrium Health Levine Cancer Institute and colleagues presented the results at the American Society for Hematology (ASH) Annual Meeting 2024.

Read the full article on CLL Society's website at: https://cllsociety.org/2025/04/challenges-and-best-practices-for-initiating-venetoclax/
__________________________________________________________________________________________
CLL Society Website: https://cllsociety.org/
Facebook: https://www.facebook.com/CLLsociety
Twitter: https://twitter.com/CllSociety
LinkedIn: https://www.linkedin.com/company/cll-society/

Видео Challenges and Best Practices for Initiating Venetoclax - Dr. Ryan Jacobs канала CLL Society